Daito Pharmaceutical CoTSE:4577 +0.40%78 Days Payable is 48.20 as of Nov. 2025, which is 11% above its 10-year median of 43.49. GuruFocus rates TSE:4577 with a GF Score™ of 78/100 and a GF Value™ of 円1,278.25 (Fairly Valued). The stock has 3 warning signs investors should review. Among 919 Drug Manufacturers companies, Daito Pharmaceutical Co ranks worse than 78.35% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Daito Pharmaceutical Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Daito Pharmaceutical Co Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Daito Pharmaceutical Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Daito Pharmaceutical Co's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Daito Pharmaceutical Co's Days Payable for the fiscal year that ended in May. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Daito Pharmaceutical Co (TSE:4577) has a Days Payable of 48.20 as of Nov. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Daito Pharmaceutical Co and its competitors. This is 11% above median its historical median of 43.49. Over the past decade, Daito Pharmaceutical Co's Days Payable has ranged from 41.41 to 50.47. According to the industry distribution chart, Daito Pharmaceutical Co ranks #720 out of 919 companies in the Drug Manufacturers industry, placing it in the top 78.3%.
Is Daito Pharmaceutical Co's Days Payable too high?
Daito Pharmaceutical Co's current Days Payable of 48.20 is 11% above median its 10-year median of 43.49. Over the past 10 years, this metric has ranged from a low of 41.41 to a high of 50.47. The Drug Manufacturers industry median Days Payable is 90.69. Daito Pharmaceutical Co's value of 48.20 is 46.9% below this industry median. Based on the distribution chart, Daito Pharmaceutical Co ranks #720 out of 919 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Daito Pharmaceutical Co has a GF Score™ of 78/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Daito Pharmaceutical Co's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Daito Pharmaceutical Co ranks #720 out of 919 companies for Days Payable. This places Daito Pharmaceutical Co in the lower half of its industry. The industry median Days Payable is 90.69. Daito Pharmaceutical Co's value of 48.20 is 46.9% below this benchmark. Historically, Daito Pharmaceutical Co's own Days Payable has ranged from 41.41 to 50.47 over the past decade. While the company's 10-year median is 43.49 vs. the industry median of 90.69, Daito Pharmaceutical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.69, based on 919 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Daito Pharmaceutical Co's current Days Payable of 48.20 is 46.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Daito Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Daito Pharmaceutical Co's current Days Payable is 48.20, which is 11% above median its own 10-year median of 43.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Daito Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Daito Pharmaceutical Co (TSE:4577) is currently considered Fairly Valued. The stock's GF Value™ is 円1,278.25, compared to a current price of 円1,246.00 — trading 2.5% below its estimated fair value. The current Days Payable is 48.20, which is 11% above median its 10-year median of 43.49 and 46.9% below the Drug Manufacturers industry median of 90.69. Daito Pharmaceutical Co's overall GF Score™ is 78/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Daito Pharmaceutical Co (TSE:4577), the current Days Payable is 48.20 as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Daito Pharmaceutical Co (TSE:4577) Overvalued in 2026?
Based on GuruFocus' analysis, Daito Pharmaceutical Co stock appears to be undervalued.
The current stock price of 円1,246.00 is trading 2.5% below its estimated GF Value™ of 円1,278.25.
GuruFocus considers Daito Pharmaceutical Co to be Fairly Valued.
Key valuation signals for TSE:4577:
Days Payable: 48.20 (11% above median its 10-year median of 43.49)
GF Value™: 円1,278.25 vs. price of 円1,246.00 (2.5% below fair value)
Industry Position: 46.9% below the Drug Manufacturers median (#720 of 919)
No single metric tells the full story. See the TSE:4577 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4577 has been successfully added to your 
